88IV - Public company info - Medlive Technology Co. Ltd.

Input the stock code or the company name

Search

Financial Ratios

Medlive Technology Co. Ltd., 02192.HK - Company Profile
Chairman	Tian Liping
Share Issued (share)	690,000,000
Par Currency	U.S. Dollar
Par Value	1.0E-5
Industry	E-Commerce & Internet Services
Corporate Profile	Business Summary: The group is the largest online professional physician platform in China. Performance for the year: The group’s revenue from pharmaceutical and medical device companies increased from RMB58.8 million in 2018 to RMB90.5 million in 2019 and further increased to RMB158.6 million in 2020, accounting for 70.5%, 74.4% and 74.3% of the group’s total revenue for the respective years. Revenue from other customers increased from RMB24.7 million in 2018 to RMB31.1 million in 2019 and further increased to RMB54.9 million in 2020, accounting for 29.5%, 25.6% and 25.7% of the group’s total revenues for the respective years. Business Review The group have focused on using technology to support physicians’ clinical decision making for over 20 years, and the group’s self-developed Medlive (醫脈通) platform is widely recognized by physicians in China as the most popular professional medical platform. As of December 31, 2020, the group’s Medlive platform, available through the group’s website, desktop application and mobile application, had approximately 3.5 million registered users, around 2.4 million of whom were licensed physicians, representing approximately 58% of all licensed physicians in China as of the same date, according to the Frost & Sullivan Report. In the fourth quarter of 2020, the average MAUs on the group’s platform exceeded 1.0 million. In the same period, the average monthly views of articles and videos by registered users on the group’s platform were over 134 million. Articles and videos on the group’s platform include, among others, clinical guides and guidelines, research articles, drug references, clinical developments, as well as customized content. Leveraging the group’s large number of physicians users and their high level of engagement, the group’s Medlive platform allows platform participants to gather, learn and connect. the group’s platform participants include physicians, pharmaceutical and medical device companies and patients. the group extensively leverage the group’s proprietary technology, content generation capabilities and the group’s understanding of medical information science to deliver the most relevant and valuable information efficiently to each group of platform participants. The group’s platform participants benefit from the powerful network effects of the group’s platform. Physicians play an essential role in the value chain of healthcare market and are the key decision makers in prescribing healthcare products. As more physicians join the group’s platform, they are able to share knowledge with, and seek support from, a larger number of professional peers. Other platform participants, such as pharmaceutical and medical device companies who are the suppliers of healthcare products, and patients who are the end-users of the healthcare products, are attracted to the group’s platform due to the group’s high quality and growing physician user base. • Solutions for Pharmaceutical and Medical Device Companies. the group primarily provide digital healthcare marketing services to pharmaceutical and medical device companies. the group ranked first among physician platform-based digital healthcare marketing service providers in China in terms of revenue in 2020, with a 21.4% market share, according to the Frost & Sullivan Report. the group also offer a highly scalable digital platform with user analytics to help pharmaceutical and medical device companies improve their efficiency and effectiveness in product development and commercialization. the group generate revenue primarily from fees paid by the group’s healthcare customers for the group’s digital detailing, digital marketing consulting and digital content creation services. The group provide patient recruitment services for clinical trials that enable pharmaceutical and medical device companies to quickly meet planned enrollment targets. the group offer RWS support solutions that enable pharmaceutical and medical device companies to collect and analyze the clinical effects of their products in the real-world environment. the group generate revenue primarily from fees paid by the group’s healthcare customers for patient recruitment service, RWS support solutions and related application software development service. • Solutions for Physicians. the group’s platform provides a setting for physicians to learn about and discuss the latest research, products and technologies available in the healthcare market and clinical best practices. the group’s platform offerings are underpinned by the professional medical content curated by the group’s own content team, which included 62 full-time medical experts and 30 full-time digital marketing content designers as of the Latest Practicable Date. For example, the group’s Clinical Guides (臨床指南) solution aggregates the latest clinical references and the group’s Clinical Drug Reference (用藥參考) solution offers comprehensive information on prescription drugs, providing efficient clinical decision-making support to physicians at their fingertips. As of the Latest Practicable Date, the group’s platform offered over 12,000 clinical guides published by medical authorities in China and overseas, prescribing information for over 30,000 prescription drugs and over 100,000 guides on drug interactions and incompatibility. the group’s platform is now well-recognized as the authoritative source for medical information in China. the group generate revenue primarily from annual membership fees charged for the group’s Clinical Guides (臨床指南), Reference Aid for Medicine (醫學文獻王), Clinical Drug Reference (用藥參考) and Medical Dictionary (全醫藥學大詞典) solutions. • Solutions for Patients. the group launched the group’s Internet hospital in 2021, which represents a major step forward in the application of the group’s intelligent patient management solutions, which entail comprehensive chronic disease management services. Patients can conveniently receive medical advice and prescriptions from physicians who participate in the group’s Internet hospital. the group also offer AI-enabled, automated patient management services through the group’s Internet hospital to educate patients about their conditions and treatment regimens, provide patients with customized chronic disease management suggestions and keep track of their medication-taking and refills. Such services are designed to increase patient adherence to prescribed medication regimens, thereby improving the effectiveness of treatments. the group started to generate revenue from commissions on fees paid by patients for online consultation services and prescription services on the group’s Internet hospital in 2021. the group also generate revenue from fees paid by non-profit organizations with medical focus and pharmaceutical companies for provision of patient education services, which leverage the group’s AI technology and medical knowledge graph, to patients and non-profit organizations. • Solutions for Hospitals. Hospitals need technology solutions to improve the efficiency of clinical trials. the group offer hospitals with electronic data capture (“EDC”) system for intelligent and automated data collection and management. 156 hospitals used the group’s EDC solutions in 2020. the group generate revenue primarily from fees paid by hospitals for EDC solutions. The group’s comprehensive solution offerings also allow us to serve other stakeholders of the healthcare industry, such as medical researchers, non-profit organizations, CROs and medical associations. Because of the group’s strong brand recognition in the medical community, The group is well-positioned to attract even more participants, such as insurance companies, to the group’s platform. The group delivered strong financial performance during the Track Record Period from operating the group’s professional physician platform. the group’s revenue increased from RMB83.5 million in 2018 to RMB121.6 million in 2019 and further increased to RMB213.5 million in 2020, at a CAGR of 59.9% from 2018 to 2020. the group’s net profit increased from RMB14.2 million in 2018 to RMB31.3 million in 2019 and further increased to RMB85.2 million in 2020, at a CAGR of 145.0% from 2018 to 2020. the group started to generate revenue from operating Internet hospital in 2021. Prospects: To achieve the group’s mission and further solidify the group’s market leadership, the group intend to pursue the following strategies: • continue to increase physician penetration and engagement by enhancing the group’s medical knowledge solutions and enriching the information and content on the group’s platform; • continue to build the group’s technological platform and expand its applications; • expand the group’s customer network and strengthen relationships with existing customers; • continue to expand the group’s service offerings, including patient care offerings with digital health management tools, and clinical research solutions; and • explore strategic partnerships, investments and acquisitions.

Information from the financial statements of listed companies

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2024

Suntek Computer Systems Limited.

All rights reserved